FDAnews
www.fdanews.com/articles/126431-clovis-signs-agreement-with-ventana-to-develop-companion-diagnostic-test

Clovis Signs Agreement With Ventana to Develop Companion Diagnostic Test

April 22, 2010
Clovis Oncology, Inc. and Ventana Medical Systems, Inc. announced Thursday that they have entered into a collaboration agreement for the development of a human equilibrative nucleoside transporter 1 (hENT1) immunohistochemistry assay, which will be used in Clovis’ CO-101 clinical trials to identify patients with low level tumor expression of hENT1 protein.
StreetInsider